T. Rowe Price Associates’s OrthoPediatrics KIDS Stock Holding History

T. Rowe Price Associates’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Buy	13,173 +2,026	+18%	+$35.2K	﹤0.01%	2918
2026 Q1	$177K	Buy	11,147 +505	+5%	+$8.82K	﹤0.01%	2877
2025 Q4	$190K	Buy	+10,642	New	+$186K	﹤0.01%	2824
2021 Q4	–	Sell	-6,461	Closed	-$423K	–	3015
2021 Q3	$423K	Hold	6,461	–	–	﹤0.01%	2451
2021 Q2	$408K	Buy	6,461 +318	+5%	+$18.3K	﹤0.01%	2472
2021 Q1	$299K	Sell	6,143 -11	-0.2%	-$528	﹤0.01%	2565
2020 Q4	$254K	Buy	+6,154	New	+$282K	﹤0.01%	2486

Other funds holding KIDS

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

T. Rowe Price Associates's KIDS Position: Q2 2026 in Review

T. Rowe Price Associates increased its OrthoPediatrics (KIDS) stake by 18% in Q2 2026, buying an estimated $35.2K and bringing the position to 13,173 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #2918.

T. Rowe Price Associates first reported a position in KIDS in Q4 2020 and has held it in 7 quarters since. The position peaked at $423K in Q3 2021. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

T. Rowe Price Associates held 13,173 shares of OrthoPediatrics worth $252K as of Q2 2026.
T. Rowe Price Associates bought 2,026 OrthoPediatrics shares in Q2 2026, an estimated $35.2K.
OrthoPediatrics made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2918 holding.
T. Rowe Price Associates first reported a position in OrthoPediatrics in Q4 2020 and has held it in 7 quarters since.
T. Rowe Price Associates's OrthoPediatrics position peaked at $423K in Q3 2021.
119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.